Finally, we show that ATG7 knockdown sensitizes CML CD34+ cells to TKI-induced death, without affecting non-CML CD34+ cells, further supporting the concept that autophagy is an important therapeutic target in CML. The gene discussed is ATG7; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.